Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice
about
The cell-rounding activity of the vesicular stomatitis virus matrix protein is due to the induction of cell deathReplication-Competent Viruses as Cancer Immunotherapeutics: Emerging Clinical DataVesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancerYellow fever virus encephalitis: properties of the brain-associated T-cell response during virus clearance in normal and gamma interferon-deficient mice and requirement for CD4+ lymphocytesUnderstanding and altering cell tropism of vesicular stomatitis virusChikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the BrainInterferon-induced tetherin restricts vesicular stomatitis virus release in neuronsPotential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer.Pseudorabies virus-induced leukocyte trafficking into the rat central nervous systemMatrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus.Prophylactic alpha interferon treatment increases the therapeutic index of oncolytic vesicular stomatitis virus virotherapy for advanced hepatocellular carcinoma in immune-competent rats.Distinct macrophage subpopulations regulate viral encephalitis but not viral clearance in the CNSRIG-I mediates nonsegmented negative-sense RNA virus-induced inflammatory immune responses of primary human astrocytes.Relative neurotropism of a recombinant rhabdovirus expressing a green fluorescent envelope glycoproteinAntiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice.Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene.Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β.Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance.Variation in susceptibility of human malignant melanomas to oncolytic vesicular stomatitis virus.Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.Immune response in the absence of neurovirulence in mice infected with m protein mutant vesicular stomatitis virus.Characterization of retinoic acid-inducible gene-I expression in primary murine glia following exposure to vesicular stomatitis virus.In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation.rVSV(M Delta 51)-M3 is an effective and safe oncolytic virus for cancer therapy.Acute infection with venezuelan equine encephalitis virus replicon particles catalyzes a systemic antiviral state and protects from lethal virus challengeMolecular determinants of susceptibility to oncolytic vesicular stomatitis virus in pancreatic adenocarcinoma.Sleep and behavior during vesicular stomatitis virus induced encephalitis in BALB/cJ and C57BL/6J miceViral CNS infections: role of glial pattern recognition receptors in neuroinflammationVesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity.The Olfactory Bulb: An Immunosensory Effector Organ during Neurotropic Viral Infections.Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapyInhibition of vesicular stomatitis virus infection by nitric oxide.Disruption of IFN-gamma- mediated antiviral activity in neurons: the role of cannabinoidsGene expression contributing to recruitment of circulating cells in response to vesicular stomatitis virus infection of the CNS.Role of peripheral immune response in microglia activation and regulation of brain chemokine and proinflammatory cytokine responses induced during VSV encephalitis.Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain.Tumor Necrosis Factor-Mediated Survival of CD169+ Cells Promotes Immune Activation during Vesicular Stomatitis Virus Infection.Nose-to-Brain Delivery of Antiviral Drugs: A Way to Overcome Their Active Efflux?
P2860
Q24679521-F7CF6FE3-ACAA-44E9-9542-0902FB64416FQ26801501-B67CB9E8-518C-40C0-8823-9B2557814482Q27021839-902413A9-D4E0-470F-AB74-3CE978A9CADEQ27469887-E9FC48EE-05F9-4714-8C89-78F2BE539A26Q27687067-A114FE44-5754-4544-86CB-FB44A1200C88Q28223031-CAC74D11-8483-4697-8F4B-825C4F8B52FBQ28585561-517AC6A7-7207-43EC-AA9C-E9988FE199E8Q33579385-217838AA-1978-41AD-865A-078E7438009FQ33785423-EC9E825C-C908-4FF3-8690-D9488A6ED7BAQ33870184-4E507761-60BB-4D09-9AA2-592DD730DA23Q34092661-A83826A9-D616-42F7-A94C-5BC35FF0A95AQ34117786-2C2106A5-BF24-4FE4-9641-2E6D8FD4112EQ34158564-C354BD1B-4D79-48D1-A563-C096E864F467Q34329802-292400AE-13F2-46FE-9BB7-9578F6B18139Q35837415-8DE3BF6B-1CED-40D9-BAE1-B453F38A35FEQ36007610-015D29CD-D003-4CBC-8250-31C875F201B9Q36049446-7AC15F16-4AA7-4799-8DE6-852558BBB1E7Q36426325-D5301EEB-2394-45B0-9350-A47EA546D2DBQ36579405-3A754C34-B8ED-41C9-930A-197FD775471FQ36751597-168AAD4F-6B26-4649-A153-DEC7F4E3B175Q36898706-477CA8E9-C0FA-40A9-850C-30DE723179C3Q37322441-DF4BCC9A-C5FE-4909-8786-B4F6AF07D3BCQ37354600-4D998321-4887-480C-8FCF-74D3BF3C182CQ37418123-8868F3D7-3E3E-4194-9125-58D2288FF4C9Q37451959-4B456D39-75B3-4AEF-BA8A-BC9D409D0D4EQ37646792-1D534FD7-6105-4E68-87AF-CE001B7CDE2BQ37648216-1ABBD605-27D9-4D2F-9673-E1B9078963F5Q38020836-D8E47CA0-57F2-4CA4-8DA7-1EC9E471384AQ38291063-CD541367-771F-4037-88E5-D496CB6052D7Q38292935-E2296A79-B794-4EDA-BBCF-58A88FD43631Q39404803-9E33FDB3-92F2-4C85-B7CF-AF9932051761Q39869594-8AB940A9-2287-48DE-829D-C281F1B732FBQ39969705-985371F9-5AC1-43D9-A732-CCC5E34C87AFQ41919786-6854A584-D3A1-4168-92F1-087EFB0CBEBFQ41981639-C0622689-B223-45F6-90F7-9509032A4D53Q42795549-FA299D0C-8619-4113-A4C0-86618342DE45Q45324796-F01E2101-692D-4ECA-8931-5C7698D37FDCQ52627559-66DC574D-2666-4231-A710-521E861228DA
P2860
Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice
@ast
Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice
@en
type
label
Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice
@ast
Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice
@en
prefLabel
Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice
@ast
Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice
@en
P2093
P2860
P1433
P1476
Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice
@en
P2093
P2860
P304
P407
P577
1993-11-01T00:00:00Z